EUVIMEDEUVIMED entdecken
Crossref

Anticoagulant Medications for Patients With Atrial Fibrillation and Advanced Renal Disease: A Propensity-Matched Real-World Analysis of Apixaban vs Rivaroxaban

Muhammad Asim Agha, Muhammad Sajawal, Hira Batool, Muhammad Ammar Agha, Hadia Batool, Aqsa Agha, Muhammad Ibrahim Khan, Miriam Michael

Georgetown Medical Review · 20.08.2026 · 10 (1)

DOI: 10.52504/001c.167471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Georgetown Medical Review, online erschienen am 20.08.2026. Verfasst von Muhammad Asim Agha und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advanced chronic kidney disease (CKD) complicates anticoagulant treatment because thromboembolic and bleeding risks compete. We compared treatment outcomes for apixaban and rivaroxaban in adults with atrial fibrillation (AF) and stage 4/5 CKD.

Methods

Deidentified TriNetX records for patients treated with apixaban (n=49,698) and rivaroxaban (n=2660) underwent 1:1 propensity score matching (demographics, medications, procedures, laboratory values); 2533 matched pairs were identified (absolute standardized mean difference

Zitieren

APA

Agha, M. A., Sajawal, M., Batool, H., Agha, M. A., Batool, H., Agha, A., Khan, M. I., & Michael, M. (2026). Anticoagulant Medications for Patients With Atrial Fibrillation and Advanced Renal Disease: A Propensity-Matched Real-World Analysis of Apixaban vs Rivaroxaban. Georgetown Medical Review, 10(1). https://doi.org/10.52504/001c.167471

Vancouver

Agha MA, Sajawal M, Batool H, Agha MA, Batool H, Agha A, et al. Anticoagulant Medications for Patients With Atrial Fibrillation and Advanced Renal Disease: A Propensity-Matched Real-World Analysis of Apixaban vs Rivaroxaban. Georgetown Medical Review. 2026;10(1). doi:10.52504/001c.167471

BibTeX
@article{Agha2026,
  author = {Agha, Muhammad Asim and Sajawal, Muhammad and Batool, Hira and Agha, Muhammad Ammar and Batool, Hadia and Agha, Aqsa and Khan, Muhammad Ibrahim and Michael, Miriam},
  title = {Anticoagulant Medications for Patients With Atrial Fibrillation and Advanced Renal Disease: A Propensity-Matched Real-World Analysis of Apixaban vs Rivaroxaban},
  journal = {Georgetown Medical Review},
  year = {2026},
  volume = {10},
  number = {1},
  doi = {10.52504/001c.167471}
}
Kostenlos starten →